Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$39.88 USD
+0.27 (0.68%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $39.86 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Apogee Therapeutics Inc. has a market cap of $1.83B, which represents its share price of $39.61 multiplied by its outstanding shares number of 46.11M. As a small-cap company, APGE's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
APGE 39.88 +0.27(0.68%)
Will APGE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for APGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APGE
Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
APGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade
Other News for APGE
Upper Bollinger Band Walk appears for APGE after 0.68% move
Slingshot Bullish appears for APGE after 0.58% move
Canaccord Genuity Sticks to Their Buy Rating for Apogee Therapeutics (APGE)
APGE forms Shooting Star Candlestick on October 1
Is APGE poised for gains? 200 Day Moving Average Support shows up after sliding 0.25%